Access and Global Health

Advancing Our Access Goals
 

We truly believe that through our capabilities and partnerships, serving patients in more than 165 countries and territories, we can contribute to progress on the sustainable development goal #3 - health and wellbeing for all.


Providing Access to ARVs

Goal: Provide ARV therapy equivalent to a total of 30 million patients, including >2 million children living with HIV/AIDS, between 2022 and the end of 2025.*

Our Progress: In 2024**, we provided treatments for ~7 million patients, including ~320,000 children living with HIV/AIDS. Since 2022, we have provided treatments for >24 million adults and children.

*Our ability to make progress on our goal depends on several factors, some of which are outside of our control, including the existence and funding of our distribution partners.
** The remediation activities at the Indore site have impacted our ARV therapy supply in 2024. We are aiming to be back on track by the end of 2025.



Promoting HCP Education and Outreach

Goal: Impact 100 million patients via HCP education and outreach regarding prevention, diagnosis and treatment options for cardiovascular disease, diabetes, cancer and other important chronic conditions to improve outcomes through the NCD Academy by the end of 2025.*

Our Progress: More than 30,000 individuals have an NCD Academy account, an increase of more than 6,000 users in 2024 over the previous year. The total number of patients impacted since the launch of NCD Academy is approximately 115 million.1

*Our ability to make progress on our goals depends on several factors, some of which are outside of our control.
(1) The calculation methodology for 2024 was updated to better reflect the cumulative patient impact of NCD Academy learners over multiple years. Under the prior year methodology, patient impact was calculated by multiplying the number of HCP learners by the average number of patients treated weekly (as self-reported by HCP learners upon registering for NCD Academy) by 50 working weeks. Using the prior year methodology, calculated patient reach would have been 92.5 million. For 2024, patient reach is now calculated at an individual HCP learner level by multiplying the number of patients treated per week, as self-reported by the individual HCP learner upon registering for NCD Academy by the number of weeks the individual was enrolled in NCD Academy (in some cases, multiple years). Patient reach for each individual learner is summed to arrive at total patient reach. Patient reach includes unique patients as well as repeat patient encounters.